This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

David H. Gutmann, MD, PhD; Arthur Aylsworth, MD; John C. Carey, MD; Bruce Korf, MD, PhD; Joan Marks, PhD; Reed E. Pyeritz, MD, PhD; Allan Rubenstein, MD; David Viskochil, MD, PhD

JAMA. 1997;278(1):51-57.

Abstract
Objective.
—Neurofibromatosis 1 and neurofibromatosis 2 are autosomal dominant genetic disorders in which affected individuals develop both benign and malignant tumors at an increased frequency. Since the original National Institutes of Health Consensus Development Conference in 1987, there has been significant progress toward a more complete understanding of the molecular bases for neurofibromatosis 1 and neurofibromatosis 2. Our objective was to determine the diagnostic criteria for neurofibromatosis 1 and neurofibromatosis 2, recommendations for the care of patients and their families at diagnosis and during routine follow-up, and the role of DNA diagnostic testing in the evaluation of these disorders.

Data Sources.
—Published reports from 1966 through 1996 obtained by MEDLINE search and studies presented at national and international meetings.

Study Selection.
—All studies were reviewed and analyzed by consensus from multiple authors.

Data Extraction.
—Peer-reviewed published data were critically evaluated by independent extraction by multiple authors.

Data Synthesis.
—The main results of the review were qualitative and were reviewed by neurofibromatosis clinical directors worldwide through an Internet Web site.

Conclusions.
—On the basis of the information presented in this review, we propose a comprehensive approach to the diagnosis and treatment of individuals with neurofibromatosis 1 and neurofibromatosis 2.

Author Affiliations
From Washington University, St Louis, Mo (Dr Gutmann); University of North Carolina, Chapel Hill (Dr Aylsworth); University of Utah, Salt Lake City (Drs Carey and Viskochil); Boston Children's Hospital, Boston, Mass (Dr Korf); Sarah Lawrence College, Bronxville, NY (Dr Marks); Allegheny University of the Health Sciences, Pittsburgh, Pa (Dr Pyeritz); and Mt Sinai School of Medicine, New York, NY (Dr Rubenstein).

Footnotes
The authors comprise the National Neurofibromatosis Foundation Clinical Care Advisory Board.

Reprints: David H. Gutmann, MD, PhD, Neurofibromatosis Program, St Louis Children's Hospital, Department of Neurology, Washington University School of Medicine, 660 S Euclid Ave, Box 8111, St Louis, MO 63110 (e-mail: gutmannd@neuro.wustl.edu).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tumor Burden in Patients with Neurofibromatosis Types 1 and 2 and Schwannomatosis: Determination on Whole-Body MR Images
Cai et al.
Radiology 2009;250:665-673.
ABSTRACT | FULL TEXT  

Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas
Tucker et al.
J. Med. Genet. 2009;46:81-85.
ABSTRACT | FULL TEXT  

Neurofibromatosis Type 1 Revisited
Williams et al.
Pediatrics 2009;123:124-133.
ABSTRACT | FULL TEXT  

Clinical Presentation of Patients With Neurofibromatosis Type 1 in Infancy and Childhood: Genetic Traits and Gender Effects
Suenobu et al.
J Child Neurol 2008;23:1282-1287.
ABSTRACT  

Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Mautner et al.
Neuro Oncol 2008;10:593-598.
ABSTRACT | FULL TEXT  

Health Supervision for Children With Neurofibromatosis
Hersh and Committee on Genetics
Pediatrics 2008;121:633-642.
ABSTRACT | FULL TEXT  

Neurofibromin as a regulator of melanocyte development and differentiation
Diwakar et al.
J. Cell Sci. 2008;121:167-177.
ABSTRACT | FULL TEXT  

Pheochromocytoma: an update on genetics and management
Karagiannis et al.
Endocr Relat Cancer 2007;14:935-956.
ABSTRACT | FULL TEXT  

Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification
De Luca et al.
J. Med. Genet. 2007;44:800-808.
ABSTRACT | FULL TEXT  

Neurofibromatosis type 1 with involvement of the enteric nerves
Hanemann et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:1163-1164.
FULL TEXT  

Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas
Amar et al.
J. Clin. Endocrinol. Metab. 2007;92:3822-3828.
ABSTRACT | FULL TEXT  

Myxoid neurofibromas of the breast: mammographical, sonographical and MRI appearances
Gokalp et al.
Br. J. Radiol. 2007;80:e234-e237.
ABSTRACT | FULL TEXT  

Germline NF1 Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1
Bausch et al.
J. Clin. Endocrinol. Metab. 2007;92:2784-2792.
ABSTRACT | FULL TEXT  

Soft Tissue Diffuse Neurofibromas: Sonographic Findings
Chen et al.
J Ultrasound Med 2007;26:513-518.
ABSTRACT | FULL TEXT  

The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1
Leonard et al.
Neurology 2006;67:1509-1512.
ABSTRACT | FULL TEXT  

Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1
Lammert et al.
J. Med. Genet. 2006;43:810-813.
ABSTRACT | FULL TEXT  

Commentary on "Inferior Mesenteric Artery Aneurysm Combined With Renal Artery Stenosis in a Patient With Neurofibromatosis"
Delis
PERSPECT VASC SURG ENDOVASC THER 2006;18:221-223.
 

Neurofibromatosis Type 1: From Presentation and Diagnosis to Vascular and Endovascular Therapy
Delis and Gloviczki
PERSPECT VASC SURG ENDOVASC THER 2006;18:226-237.
ABSTRACT  

Comprehensive Mutation Scanning of NF1 in Apparently Sporadic Cases of Pheochromocytoma
Bausch et al.
J. Clin. Endocrinol. Metab. 2006;91:3478-3481.
ABSTRACT | FULL TEXT  

Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes?
Jimenez et al.
J. Clin. Endocrinol. Metab. 2006;91:2851-2858.
ABSTRACT | FULL TEXT  

Case records of the Massachusetts General Hospital. Case 23-2006. A 36-year-old man with numbness in the right hand and hypertension.
Iliopoulos et al.
NEJM 2006;355:394-402.
FULL TEXT  

Increasing the specificity of diagnostic criteria for schwannomatosis
Baser et al.
Neurology 2006;66:730-732.
ABSTRACT | FULL TEXT  

Lack of Evidence for an Association Between Neurofibromatosis and Pulmonary Fibrosis
Ryu et al.
Chest 2005;128:2381-2386.
ABSTRACT | FULL TEXT  

Middle Aortic Syndrome: From Presentation to Contemporary Open Surgical and Endovascular Treatment
Delis and Gloviczki
PERSPECT VASC SURG ENDOVASC THER 2005;17:187-203.
ABSTRACT  

Management of Head and Neck Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis Type 1
Wise et al.
Arch Otolaryngol Head Neck Surg 2005;131:712-718.
ABSTRACT | FULL TEXT  

Association between benign and malignant peripheral nerve sheath tumors in NF1
Tucker et al.
Neurology 2005;65:205-211.
ABSTRACT | FULL TEXT  

Diagnostic criteria for schwannomatosis
MacCollin et al.
Neurology 2005;64:1838-1845.
ABSTRACT | FULL TEXT  

Neurofibromin Regulates Neural Stem Cell Proliferation, Survival, and Astroglial Differentiation In Vitro and In Vivo
Dasgupta and Gutmann
J. Neurosci. 2005;25:5584-5594.
ABSTRACT | FULL TEXT  

Case 13-2005 - A 48-Year-Old Man with Weakness of the Limbs and Multiple Tumors of Spinal Nerves
Korf et al.
NEJM 2005;352:1800-1808.
FULL TEXT  

Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in Patients with Neurofibromatosis Type 1
Lim et al.
Am. J. Roentgenol. 2005;184:962-968.
ABSTRACT | FULL TEXT  

From the Archives of the AFIP: Abdominal Neoplasms in Patients with Neurofibromatosis Type 1: Radiologic-Pathologic Correlation
Levy et al.
RadioGraphics 2005;25:455-480.
ABSTRACT | FULL TEXT  

Prevalence of Neurofibromatosis 1 in German Children at Elementary School Enrollment
Lammert et al.
Arch Dermatol 2005;141:71-74.
ABSTRACT | FULL TEXT  

Gastrointestinal Stromal Tumors in Patients with Neurofibromatosis: Imaging Features with Clinicopathologic Correlation
Levy et al.
Am. J. Roentgenol. 2004;183:1629-1636.
ABSTRACT | FULL TEXT  

Ophthalmological manifestations in segmental neurofibromatosis type 1
Ruggieri et al.
Br. J. Ophthalmol. 2004;88:1429-1433.
ABSTRACT | FULL TEXT  

Mechanisms and Roles of Axon-Schwann Cell Interactions
Corfas et al.
J. Neurosci. 2004;24:9250-9260.
FULL TEXT  

Clinical picture of bilateral vestibular schwannomas, sudden bilateral hearing loss, and aviation
Healy and Wood
Neurology 2004;63:933-933.
FULL TEXT  

N-Butylcyanoacrylate Embolization of a Middle Meningeal Artery Aneurysm in a Patient with Neurofibromatosis Type 2
Lesley et al.
Am. J. Neuroradiol. 2004;25:1414-1416.
ABSTRACT | FULL TEXT  

Circulating Growth Factor Levels Are Associated with Tumorigenesis in Neurofibromatosis Type 1
Mashour et al.
Clin. Cancer Res. 2004;10:5677-5683.
ABSTRACT | FULL TEXT  

The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
Kaltsas et al.
Endocr. Rev. 2004;25:458-511.
ABSTRACT | FULL TEXT  

Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1
Tada et al.
Neuro Oncol 2003;5:228-234.
ABSTRACT  

Neurofibromatosis 2 in a patient with a de novo balanced reciprocal translocation 46,X,t(X;22)(p11.2;q11.2)
Bovie et al.
J. Med. Genet. 2003;40:682-684.
FULL TEXT  

Pheochromocytoma: The Expanding Genetic Differential Diagnosis
Bryant et al.
JNCI J Natl Cancer Inst 2003;95:1196-1204.
ABSTRACT | FULL TEXT  

Hypertrophic Neuropathies and Malignant Peripheral Nerve Sheath Tumors in Transgenic Mice Overexpressing Glial Growth Factor {beta}3 in Myelinating Schwann Cells
Huijbregts et al.
J. Neurosci. 2003;23:7269-7280.
ABSTRACT | FULL TEXT  

Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients
Ars et al.
J. Med. Genet. 2003;40:e82-82.
FULL TEXT  

NF1 mutations and clinical spectrum in patients with spinal neurofibromas
Kluwe et al.
J. Med. Genet. 2003;40:368-371.
FULL TEXT  

Progesterone Receptor Expression in Neurofibromas
McLaughlin and Jacks
Cancer Res. 2003;63:752-755.
ABSTRACT | FULL TEXT  

Clinical Risk Factors for Mortality in Patients With Neurofibromatosis 1: A Cohort Study of 378 Patients
Khosrotehrani et al.
Arch Dermatol 2003;139:187-191.
ABSTRACT | FULL TEXT  

Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas
Kluwe et al.
J. Med. Genet. 2003;40:109-114.
ABSTRACT | FULL TEXT  

MR Imaging of Spinal Tumors in Children with Neurofibromatosis 1
Khong et al.
Am. J. Roentgenol. 2003;180:413-417.
ABSTRACT | FULL TEXT  

Evaluation of clinical diagnostic criteria for neurofibromatosis 2
Baser et al.
Neurology 2002;59:1759-1765.
ABSTRACT | FULL TEXT  

Review Article : Neurofibromatosis 1: Clinical Manifestations and Diagnostic Criteria
Friedman
J Child Neurol 2002;17:548-554.
ABSTRACT  

Review Article : Neurofibromas in Children With Neurofibromatosis 1
Rosser and Packer
J Child Neurol 2002;17:585-591.
ABSTRACT  

Review Article : Neurofibromin in the Brain
Gutmann
J Child Neurol 2002;17:592-601.
ABSTRACT  

Review Article : Neurofibromatosis 1: Clinical Review and Exceptions to the Rules
Young et al.
J Child Neurol 2002;17:613-621.
ABSTRACT  

Development and Implementation of a Carboplatin Desensitization Protocol for Children with Neurofibromatosis, Type 1 and Hypersensitivity Reactions in an Outpatient Oncology Clinic
Ogle et al.
Journal of Pediatric Oncology Nursing 2002;19:122-126.
ABSTRACT  

Altered Calcium-Mediated Cell Signaling in Keratinocytes Cultured from Patients with Neurofibromatosis Type 1
Korkiamaki et al.
Am. J. Pathol. 2002;160:1981-1990.
ABSTRACT | FULL TEXT  

Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2
Sperfeld et al.
Brain 2002;125:996-1004.
ABSTRACT | FULL TEXT  

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patients
Guillamo et al.
Brain 2002;126:152-160.
ABSTRACT | FULL TEXT  

Optic Pathway Glioma: Correlation of Imaging Findings with the Presence of Neurofibromatosis
Kornreich et al.
Am. J. Neuroradiol. 2001;22:1963-1969.
ABSTRACT | FULL TEXT  

Quality-of-Life Impairment in Neurofibromatosis Type 1: A Cross-sectional Study of 128 Cases
Wolkenstein et al.
Arch Dermatol 2001;137:1421-1425.
ABSTRACT | FULL TEXT  

Cerebellopontine Angle Tumor Composed of Schwann and Meningeal Proliferations
Chen et al.
Arch Otolaryngol Head Neck Surg 2001;127:1385-1389.
ABSTRACT | FULL TEXT  

Lack of Evidence for an Association Between Neurofibromatosis Type I and Intracranial Aneurysms: Autopsy Study and Review of the Literature
Conway et al.
Stroke 2001;32:2481-2485.
ABSTRACT | FULL TEXT  

NF1 Deletions in S-100 Protein-Positive and Negative Cells of Sporadic and Neurofibromatosis 1 (NF1)-Associated Plexiform Neurofibromas and Malignant Peripheral Nerve Sheath Tumors
Perry et al.
Am. J. Pathol. 2001;159:57-61.
ABSTRACT | FULL TEXT  

A clinical study of patients with multiple isolated neurofibromas
Blakley et al.
J. Med. Genet. 2001;38:485-488.
FULL TEXT  

The clinical and diagnostic implications mosaicism in the neurofibromatoses
Ruggieri and Huson
Neurology 2001;56:1433-1443.
ABSTRACT | FULL TEXT  

Why do benign astrocytomas become malignant in NF1?
Ruggieri and Packer
Neurology 2001;56:827-827.
FULL TEXT  

Neurofibromatosis: clinical presentations and anaesthetic implications
Hirsch et al.
Br J Anaesth 2001;86:555-564.
ABSTRACT | FULL TEXT  

Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain
Zhu et al.
Genes Dev. 2001;15:859-876.
ABSTRACT | FULL TEXT  

High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH
Bruder et al.
Hum Mol Genet 2001;10:271-282.
ABSTRACT | FULL TEXT  

Tumorigenic Properties of Neurofibromin-Deficient Neurofibroma Schwann Cells
Muir et al.
Am. J. Pathol. 2001;158:501-513.
ABSTRACT | FULL TEXT  

Intramedullary and Spinal Canal Tumors in Patients with Neurofibromatosis 2: MR Imaging Findings and Correlation with Genotype
Patronas et al.
Radiology 2001;218:434-442.
ABSTRACT | FULL TEXT  

Neurofibromatosis type 2
Evans et al.
J. Med. Genet. 2000;37:897-904.
ABSTRACT | FULL TEXT  

Growth in North American white children with neurofibromatosis 1 (NF1)
Szudek et al.
J. Med. Genet. 2000;37:933-938.
ABSTRACT | FULL TEXT  

A clinical assessment of neurofibromatosis type 1 (NF1) and segmental NF in northern Finland
POYHONEN
J. Med. Genet. 2000;37:43e-43.
FULL TEXT  

Malignancy in Neurofibromatosis Type 1
Korf
The Oncologist 2000;5:477-485.
ABSTRACT | FULL TEXT  

Occult Neurofibroma and Increased S100 Protein in the Skin of Patients With Neurofibromatosis Type 1: New Insight to the Etiopathomechanism of Neurofibromas
Karvonen et al.
Arch Dermatol 2000;136:1207-1209.
ABSTRACT | FULL TEXT  

Pathological Case of the Month
Arnold et al.
Arch Pediatr Adolesc Med 2000;154:961-962.
FULL TEXT  

Evidence based medicine in practice: lessons from a Scottish clinical genetics project
Campbell et al.
J. Med. Genet. 2000;37:684-691.
ABSTRACT | FULL TEXT  

Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland
POYHONEN et al.
J. Med. Genet. 2000;37:632-636.
FULL TEXT  

Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2
BASER et al.
J. Med. Genet. 2000;37:542-543.
FULL TEXT  

Use of ""unidentified bright objects"" on MRI for diagnosis of neurofibromatosis 1 in children
DeBella et al.
Neurology 2000;54:1646-1651.
ABSTRACT | FULL TEXT  

Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1
Rutkowski et al.
Hum Mol Genet 2000;9:1059-1066.
ABSTRACT | FULL TEXT  

Bilateral Diaphragm Paralysis Secondary to Central von Recklinghausen’s Disease
Hassoun and Celli
Chest 2000;117:1196-1200.
ABSTRACT | FULL TEXT  

Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children
DeBella et al.
Pediatrics 2000;105:608-614.
ABSTRACT | FULL TEXT  

The question of familial meningiomas and schwannomas:: NF2B or not to be?
King and Gutmann
Neurology 2000;54:4-4.
FULL TEXT  

Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas
Antinheimo et al.
Neurology 2000;54:71-71.
ABSTRACT | FULL TEXT  

NF1 microdeletion breakpoints are clustered at flanking repetitive sequences
Dorschner et al.
Hum Mol Genet 2000;9:35-46.
ABSTRACT | FULL TEXT  

Expression of the Neurofibromatosis Type 2 Gene in Human Tissues
den Bakker et al.
J. Histochem. Cytochem. 1999;47:1471-1480.
ABSTRACT | FULL TEXT  

Learning Disabilities in Neurofibromatosis 1: Sizing Up the Brain
Gutmann
Arch Neurol 1999;56:1322-1323.
FULL TEXT  

Neurology and the skin
Hurko and Provost
J. Neurol. Neurosurg. Psychiatry 1999;66:417-430.
FULL TEXT  

Neurological complications of neurofibromatosis type 1 in adulthood
Creange et al.
Brain 1999;122:473-481.
ABSTRACT | FULL TEXT  

Ganglioneuroblastoma and Ganglioneuroma in Association With Neurofibromatosis Type I: Report of Three Cases
Geraci et al.
J Child Neurol 1998;13:356-358.
 

Mutations of the NF1 Gene in Children With Juvenile Myelomonocytic Leukemia Without Clinical Evidence of Neurofibromatosis, Type 1 
Side et al.
Blood 1998;92:267-272.
ABSTRACT | FULL TEXT  

Recent Insights Into Neurofibromatosis Type 1: Clear Genetic Progress
Gutmann
Arch Neurol 1998;55:778-780.
FULL TEXT  

A role for Pak protein kinases in Schwann cell transformation
Tang et al.
Proc. Natl. Acad. Sci. USA 1998;95:5139-5144.
ABSTRACT | FULL TEXT  

Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart
Lakkis and Epstein
Development 1998;125:4359-4367.
ABSTRACT  

Physiatry and Care of Patients With Neurofibromatosis
Levy and Krietemeyer
JAMA 1997;278:1493-1494.
ABSTRACT  

Single Cell Ras-GTP Analysis Reveals Altered Ras Activity in a Subpopulation of Neurofibroma Schwann Cells but Not Fibroblasts
Sherman et al.
J. Biol. Chem. 2000;275:30740-30745.
ABSTRACT | FULL TEXT